Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T21:41:49.641Z.
Calculation as of: 2026-10-06T21:41:49.641Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76b79f67d555c15c1d19b9a53ec9076b1294dcb64452140a50102a9ec63499e7
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2016-11-14.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
PS RATIO AVG TTM
N/A
PS RATIO AVG 3Y
N/A
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$7.67M
PS Ratio
N/A
TTM Avg
1162916.20
3Y Avg
640325.60
5Y Avg
640325.60
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | $8.04M | N/A | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | 1.00 | 0.68 | 1.19 | 1.19 |
| HeartSciences Inc. (HSCS)vs › | $8.14M | N/A | 795.02 | 643.34 | 689.54 |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | N/A | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | N/A | 33.16 | 27.80 | 27.84 |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | 0.32 | 0.20 | 0.21 | 0.26 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | N/A | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | N/A | 1162916.20 | 640325.60 | 640325.60 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | 24.22 | 20.17 | 15.94 | 138.16 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.46M | N/A | N/A | N/A | N/A |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-02 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $0 |
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2016-11-14 | 1262.12 |
| 2016-11-11 | 1126.89 |
| 2016-11-10 | 723.01 |
| 2016-11-09 | 1460.45 |
| 2016-11-08 | 1595.68 |
| 2016-11-07 | 1262.12 |
| 2016-11-04 | 991.67 |
| 2016-11-03 | 887.99 |
| 2016-11-02 | 761.44 |
| 2016-11-01 | 1036.74 |
| 2016-10-31 | 1217.04 |
| 2016-10-28 | 1262.12 |
| 2016-10-26 | 1307.20 |
| 2016-10-25 | 1392.83 |
| 2016-10-24 | 1307.20 |
| 2016-10-20 | 1622.73 |
| 2016-10-19 | 1532.57 |
| 2016-10-18 | 1352.27 |
| 2016-10-13 | 1352.27 |
| 2016-10-12 | 1443.55 |
| 2016-10-11 | 1712.88 |
| 2016-10-10 | 1763.62 |
| 2016-10-04 | 1622.73 |
| 2016-09-12 | 1893.18 |
| 2016-09-06 | 1730.91 |
| 2016-08-29 | 1631.74 |
| 2016-08-26 | 1757.95 |
| 2016-08-24 | 1983.33 |
| 2016-08-18 | 2045.54 |
| 2016-08-17 | 2077.99 |
| 2016-08-16 | 2524.24 |
| 2016-08-15 | 2073.48 |
| 2016-08-12 | 1803.03 |
| 2016-08-09 | 177.39 |
| 2016-08-08 | 181.42 |
| 2016-08-04 | 170.34 |
| 2016-08-03 | 153.20 |
| 2016-08-02 | 152.19 |
| 2016-08-01 | 171.34 |
| 2016-07-29 | 191.50 |
| 2016-07-28 | 192.01 |
| 2016-07-27 | 251.98 |
| 2016-07-26 | 272.03 |
| 2016-07-25 | 312.45 |
| 2016-07-22 | 319.47 |
| 2016-07-21 | 314.77 |
| 2016-07-20 | 322.53 |
| 2016-07-19 | 302.37 |
| 2016-07-18 | 302.37 |
| 2016-07-15 | 322.53 |
| 2016-07-14 | 319.38 |
| 2016-07-13 | 322.43 |
| 2016-07-12 | 317.49 |
| 2016-07-11 | 307.41 |
| 2016-07-08 | 327.57 |
| 2016-07-07 | 332.61 |
| 2016-07-06 | 332.61 |
| 2016-07-05 | 352.77 |
| 2016-06-30 | 362.85 |
| 2016-06-29 | 337.65 |
| 2016-06-28 | 332.61 |
| 2016-06-27 | 352.77 |
| 2016-06-24 | 393.08 |
| 2016-06-23 | 393.08 |
| 2016-06-22 | 362.85 |
| 2016-06-21 | 407.80 |
| 2016-06-20 | 332.61 |
| 2016-06-17 | 320.51 |
| 2016-06-16 | 352.77 |
| 2016-06-14 | 367.78 |
| 2016-06-09 | 335.13 |
| 2016-06-07 | 403.16 |
| 2016-03-29 | 815.66 |
| 2016-03-28 | 908.99 |
